Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years

Historically, neoadjuvant chemotherapy (NACT) was extrapolated from adjuvant regimens. Dual HER2 blockade and the introduction of carboplatin for triple negative breast cancers (TNBC) emerged by December 2013 and have improved pathological complete response (pCR) rates. The objective of this study w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Oncol
Main Authors: McFarland, Daniel C., Naikan, Jessica, Rozenblit, Mariya, Mandeli, John, Bleiweiss, Ira, Tiersten, Amy
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2016
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4921638/
https://ncbi.nlm.nih.gov/pubmed/27382369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4324863
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares